Sanofi Consumer Healthcare India Limited
NSE: SANOFICONR | Information Technology
Market Fundamentals
Stock Intelligence & News
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated April 28, 2026, titled "Sanofi Consumer Healthcare India Limited reports Q1 26 Revenue at ₹2,292 MN, Net Profit at ₹678 MN". |SUBJECT: Press Release
Read Full Analysis →Sanofi India Limited
Sanofi India Limited has informed the Exchange regarding Change in Director(s) of the company. |SUBJECT: Change in Director(s)
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Gujarat-based pharma stock jumps over 15% despite stock market crash; here's why
Gujarat Themis Biosyn shares surged over 15% as the company announced plans to acquire 13 anti-TB and anti-infective brands from Sanofi for Euro 158 million. The deal, expected to close by December 2026, will enhance earnings and expand its global pharmaceutical presence.
Read Full Analysis →Gujarat Themis Biosyn To Acquire Sanofi Portfolio For Rs 1,700 Crore
The deal is expected to be closed by the end of December 2026 and will be funded by an optimal mix of debt and equity.
Read Full Analysis →Sanofi Consumer Healthcare India Limited
Board Meeting Intimation |Meeting Date: 28-Apr-2026
Read Full Analysis →Sanofi Consumer Healthcare India Limited
Financial Results |Meeting Date: 28-Apr-2026
Read Full Analysis →Sanofi Leans On Dupixent For First-Quarter Beat A Week Ahead Of New CEO
Sanofi Leans On Dupixent For First-Quarter Beat A Week Ahead Of New CEO
Read Full Analysis →Sanofi climbs as strong Dupixent sales drive Q1 revenue and profit beat
Sanofi climbs as strong Dupixent sales drive Q1 revenue and profit beat
Read Full Analysis →FDA approves Sanofi’s Tzield for children as young as one year
FDA approves Sanofi’s Tzield for children as young as one year
Read Full Analysis →Get instant alerts when SANOFICONR breaks news
Join investors who track Sanofi Consumer Healthcare India Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SANOFICONR?
SANOFICONR is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Sanofi Consumer Healthcare India Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SANOFICONR to your custom watchlist.